ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer-Reference-Cited by-同舟云学术

ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer

Published:2020-10-15 Issue:6 Volume:44 Page:2735-2745
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Shimizu Kosuke¹,Matsumoto Hiroaki¹,Hirata Hiroshi¹,Ueno Koji²,Samoto Masahiro¹,Mori Junichi¹,Fujii Nakanori³,Kawai Yoshihisa⁴,Inoue Ryo¹,Yamamoto Yoshiaki¹,Yano Seiji¹,Shimabukuro Tomoyuki¹,Furutani-Seiki Makoto⁵,Matsuyama Hideyasu¹

Affiliation:

1. Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755-8505, Japan

2. Center for Regenerative Medicine, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755-8505, Japan

3. Department of Urology, Japan Community Health Care Organization Tokuyama Central Hospital, Shunan, Yamaguchi 745-8522, Japan

4. Kawai Urological Clinic, Hofu, Yamaguchi 747-0836, Japan

5. Department of Systems Biochemistry in Pathology and Regeneration, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi 755-8505, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARHGAP29 Is Involved in Increased Invasiveness of Tamoxifen-resistant Breast Cancer Cells and its Expression Levels Correlate With Clinical Tumor Parameters of Breast Cancer Patients;Cancer Genomics - Proteomics;2024-06-29

2. TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner;Cellular Oncology;2023-04-17

3. ARHGAP29 is required for keratinocyte proliferation and migration;2023-02-01

4. A prognostic model and immune regulation analysis of uterine corpus endometrial carcinoma based on cellular senescence;Frontiers in Oncology;2022-12-08

5. ARHGAP44 expression is associated with the metastasis of osteosarcoma and is a promising prognostic biomarker;Journal of Orthopaedic Research;2022-11-12